Cargando…

Trend analysis of carbapenem-resistant Gram-negative bacteria and antimicrobial consumption in the post-COVID-19 era: an extra challenge for healthcare institutions

The incidence density trend of the carbapenem-resistant Gram-negative bacteria was analysed in device-associated infections and antimicrobial consumption in 99 critical care facilities in a low/middle-income country, between January 2019 and December 2020. Carbapenem-resistant Acinetobacter baumanni...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Carvalho Hessel Dias, V.M., Tuon, F., de Jesus Capelo, P., Telles, J.P., Fortaleza, C.M.C.B., Pellegrino Baena, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Healthcare Infection Society. Published by Elsevier Ltd. 2022
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603865/ https://www.ncbi.nlm.nih.gov/pubmed/34808311 http://dx.doi.org/10.1016/j.jhin.2021.11.011

Ejemplares similares

Active surveillance of carbapenem-resistant Gram-negative healthcare-associated infections in a low-middle-income country city
por: Dias, Viviane Maria de Carvalho Hessel, et al.
Publicado: (2021)

Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review
por: Zequinão, Tiago, et al.
Publicado: (2020)

Antimicrobial Stewardship Programs: A Review of Strategies to Avoid Polymyxins and Carbapenems Misuse in Low Middle-Income Countries
por: de Carvalho, Fabrício Rodrigues Torres, et al.
Publicado: (2022)

Oral doxycycline to carbapenem-resistant Acinetobacter baumannii infection as a polymyxin-sparing strategy: results from a retrospective cohort
por: Tuon, Felipe Francisco, et al.
Publicado: (2023)

Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia
por: Cetin, Sinan, et al.
Publicado: (2021)

Effectiveness of a double-carbapenem combinations against carbapenem-resistant Gram-negative bacteria
por: Lu, Jiayue, et al.
Publicado: (2022)

Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria
por: Garg, Atul, et al.
Publicado: (2019)

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
por: Nordmann, Patrice, et al.
Publicado: (2019)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections
por: Tabak, Ying P., et al.
Publicado: (2020)

Using Molecular Diagnostics to Develop Therapeutic Strategies for Carbapenem-Resistant Gram-Negative Infections
por: Tenover, Fred C.
Publicado: (2021)

In Vitro Activity of Essential Oils Against Gram-Positive and Gram-Negative Clinical Isolates, Including Carbapenem-Resistant Enterobacteriaceae
por: Patterson, Jan E, et al.
Publicado: (2019)

The role of carbapenems in initial therapy for serious Gram-negative infections
por: Rahal, James J
Publicado: (2008)

Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
por: Ramphal, Reuben
Publicado: (2008)

Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
por: Lee, Chang-Seop, et al.
Publicado: (2014)

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
por: Doi, Yohei
Publicado: (2019)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria
por: Dropa, Milena, et al.
Publicado: (2022)

Clonal dissemination of methicillin sensitive and resistant Staphylococcus aureus among indigenous populations of the amazon and the southeast region in Brazil
por: Abraão, LM, et al.
Publicado: (2015)

Carbapenems and valproate: A consumptive relationship
por: Bede, Peter, et al.
Publicado: (2016)

The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan”
por: Mancuso, Giuseppe, et al.
Publicado: (2023)

Predictive Score for Carbapenem-Resistant Gram-Negative Bacilli Sepsis: Single-Center Prospective Cohort Study
por: Gomes, Marisa Zenaide Ribeiro, et al.
Publicado: (2022)

Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo
por: El Hafi, Bassam, et al.
Publicado: (2019)

Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019
por: Liang, Chunhong, et al.
Publicado: (2021)

In vitro Susceptibility Testing of Essential Oils against Gram-positive and Gram-negative Clinical Isolates, including Carbapenem-resistant Enterobacteriaceae (CRE)
por: Patterson, Jan E, et al.
Publicado: (2017)

Safety of a Carbapenem Restriction Policy in Patients with Gram-Negative Bacteremia
por: Mani, Nandita S, et al.
Publicado: (2017)

Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods
por: Richter, Stefan E, et al.
Publicado: (2019)

The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
por: Chopra, Teena
Publicado: (2021)

Emergence of Carbapenem-Resistant Gram-Negative Isolates in Hospital Settings in Djibouti
por: Ragueh, Ayan Ali, et al.
Publicado: (2023)

Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
por: Rivera-Villegas, Hector Orlando, et al.
Publicado: (2023)

Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study
por: McCann, Eilish, et al.
Publicado: (2018)

Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014
por: Yang, Ping, et al.
Publicado: (2018)

Drug Resistance and Molecular Epidemiology of Carbapenem Resistant Gram-negative Bacilli Isolates
por: Naim, Huma, et al.
Publicado: (2018)

Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
por: Bourafa, Nadjette, et al.
Publicado: (2018)

The threat of carbapenem-resistant gram-negative bacteria in a Middle East region
por: Davoudi-Monfared, Effat, et al.
Publicado: (2018)

Isoalantolactone restores the sensitivity of gram‐negative Enterobacteriaceae carrying MCR‐1 to carbapenems
por: Lu, Na, et al.
Publicado: (2020)

Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections
por: Xia, G. L., et al.
Publicado: (2021)

Characteristics of Carbapenem-Resistant Gram-Negative Bacilli in Patients with Ventilator-Associated Pneumonia
por: Mohamed, Amira, et al.
Publicado: (2021)

Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates
por: Schultze, Tilman G., et al.
Publicado: (2021)

Susceptibility of cefiderocol and other antibiotics against carbapenem-resistant, Gram-negative bacteria
por: Wang, Yifan, et al.
Publicado: (2022)

The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections
por: Bouza, Emilio
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lcelftasehu7pafiqf1eijv325